A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that senior executives at the pharma ...

GSK PLC closed 15.86% short of its 52-week high of £16.79, which the company achieved on September 9th.

MRNA's mRNA-1010 flu vaccine outperforms GSK's shot by 26.6% in a large phase III trial of adults 50 and older.

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

This summary encapsulates recent health updates including Carmat's insolvency filing, Bayer's glyphosate litigation in the U.S. Supreme Court, FDA's label revisions for ADHD stimulants, a U.S. House ...

In a bold move to combat childhood vulnerability to preventable diseases, Save the Children's Immunisation Accelerator has ...

The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...

In February 2025 Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Diversified Trust Co bought a new position in shares of GSK PLC Sponsored ADR (NYSE:GSK – Free Report) during the 1st quarter ...

Sequoia Financial Advisors LLC grew its holdings in shares of GSK PLC Sponsored ADR (NYSE:GSK – Free Report) by 12.8% during ...

It was announced last year that work at the GlaxoSmithKline plant in Ulverston would cease, which came to pass at the end of June.